4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000119
EVP Research sold 6,363 shares at an average $1,153.15 ($7,337,505)
- EVP Research gave up 13,637 shares (to pay taxes)
- EVP Research acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MURPHY ANDREW J · EVP Research
Table I: Non-derivative
20 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $399.66 | $7,993,200 | 68,306 | D |
| 2024-08-13 | Shares withheld for taxes : show line 2 in the form 10b5-1 | −13,637 | $1,141.49 | $15,566,499 | 54,669 | D |
| 2024-08-14 | Sale : show line 3 in the form 10b5-1 | −55 | $1,140.31 | $62,717 | 54,614 | D |
| 2024-08-14 | Sale : show line 4 in the form 10b5-1 | −48 | $1,142.94 | $54,861 | 54,566 | D |
| 2024-08-14 | Sale : show line 5 in the form 10b5-1 | −79 | $1,143.28 | $90,319 | 54,487 | D |
| 2024-08-14 | Sale : show line 6 in the form 10b5-1 | −45 | $1,144.89 | $51,520 | 54,442 | D |
| 2024-08-14 | Sale : show line 7 in the form 10b5-1 | −148 | $1,145.58 | $169,546 | 54,294 | D |
| 2024-08-14 | Sale : show line 8 in the form 10b5-1 | −51 | $1,146.60 | $58,477 | 54,243 | D |
| Open-market sales · 6,363 sh · avg $1,153.15 · $7,337,505 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-13 | Exercise or conversion : show line 21 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −20,000 | 0 | D |
Loading xslF345X05/edgardoc.xml…